DANA DESANTIS: Open Payments
NPI 1831740158 · OKEECHOBEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 108 payments from 13 companies in 2025. Trend: 2023 $130 · 2024 $975 · 2025 $2,102
Food & beverage: $2,030Education: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $346 |
| Otsuka America Pharmaceutical, Inc. | 9 | $266 |
| Alkermes, Inc. | 17 | $265 |
| Teva Pharmaceuticals USA, Inc. | 8 | $262 |
| Axsome Therapeutics, Inc. | 16 | $232 |
| Lundbeck LLC | 9 | $202 |
| E.R. Squibb & Sons, L.L.C. | 7 | $146 |
| Janssen Pharmaceuticals, Inc | 5 | $124 |
| Supernus Pharmaceuticals, Inc. | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
Products named: REXULTI, VRAYLAR, Auvelity, ARISTADA, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, Qelbree.
Industry payments across FL — which companies pay providers there.
